Immunization Action Coalition and the Hepatitis B Coalition

IAC EXPRESS

Previous issues index

IAC Home page

Issue Number 126            November 10, 1999

CONTENTS OF THIS ISSUE

  1. New "Corrections Page" on the Immunization Action Coalition's website alerts readers to incorrect information in Coalition publications
  2. CORRECTION: "Ask the Experts," General Vaccine Questions, fall/winter 1999-2000 issue of "NEEDLE TIPS"

----------------------------------------------------------

Back to Top

(1)
November 10, 1999
NEW "CORRECTIONS PAGE" ON THE IMMUNIZATION ACTION
COALITION'S WEBSITE ALERTS READERS TO INCORRECT 
INFORMATION IN COALITION PUBLICATIONS

Dear Friends of the Coalition:

All of us at the Immunization Action Coalition (IAC) work tirelessly to ensure the accuracy of the information we make available. As part of this effort, we have created a "Corrections Page" to serve as the central location for all important changes to items we have published in our two print publications, "NEEDLE TIPS and the Hepatitis B Coalition News" and "VACCINATE ADULTS!," as well as in IAC EXPRESS, our Internet news and announcement service, and on our website, http://www.immunize.org

Our procedure will be to publish in IAC EXPRESS notices of corrections to our publications and to present them chronologically on the "Corrections Page."

We welcome your "eagle-eyed" oversight of the content of our publications. If you believe you have found an error, please notify us as soon as possible so that we may evaluate the item immediately and determine the need for a formal "correction."

On the "Corrections Page" you will find only "serious" corrections for example, those that misrepresent fact and/or could result in clinical errors. Though we are also concerned about correcting administrative information such as contact names and phone numbers presented in our publications, these types of revisions will probably not appear on the "Corrections Page." Whether an error is big or small, we always want to know whenever you spot one.

To ensure that everyone receives the most up-to-date information, we ask that you encourage your colleagues and anyone else who might receive IAC publications to sign up for IAC EXPRESS.  (http://www.immunize.org/express/) Once they have subscribed, they will begin to receive any notices of corrections to Coalition publications as soon as these changes are made available. To subscribe to IAC EXPRESS, send an e-mail message to express@immunize.org and enter the word SUBSCRIBE in the "Subject:" field. (It is not necessary to type any information in the "Message" block.)

With your help, we will continue to provide you with the most accurate information possible.

Sincerely,

Deborah L. Wexler, MD
Executive Director

To visit the new "Corrections Page" on IAC's website, go to: http://www.immunize.org/corrections/index.htm
------------------------------------------------------------

Back to Top

(2)
November 8, 1999
CORRECTION: "ASK THE EXPERTS," GENERAL VACCINE QUESTIONS, FALL/WINTER 1999-2000 ISSUE OF "NEEDLE TIPS" 

"ASK THE EXPERTS" CORRECTION
In the fall/winter 1999-2000 issue of "NEEDLE TIPS and the Hepatitis B Coalition News," there is incorrect information in the answer to an "Ask the Experts" question appearing under "General Questions" on page 15. The answer provided by Dr. William Atkinson, medical epidemiologist at the  National Immunization Program, Centers for Disease Control and Prevention, was incorrect about the components of the pentavalent vaccine for infants in use in Canada. Dr. Atkinson reported that the combination vaccine used in  Canada contains whole cell pertussis vaccine when, in fact, it does not. The revised answer which follows should be substituted for the original answer that appeared in "NEEDLE TIPS."

THE QUESTION READS:
"I've heard there is a pentavalent vaccine for infants in use in Canada. When will a pentavalent vaccine be available in the U.S.?"

THE REVISED ANSWER:
"The Canadian vaccine (PENTACEL distributed by Pasteur Merieux Connaught, Canada) is a combination of acellular pertussis, diphtheria, and tetanus toxoids, Hib and inactivated polio vaccines. In the United States, trials  of new combination vaccines are in progress and some of these may be licensed in the future. SmithKline Beecham has recently applied to the Food and Drug Administration for approval of a new DTaP-IPV-Hep B combination vaccine."

ADDITIONAL COMMENTS:
The current pentavalent vaccine used for primary immunization of infants in all Canadian provinces and territories is a combination of acellular pertussis, diphtheria and tetanus toxoids, and Hib and inactivated polio vaccines (PENTACEL distributed by Pasteur Merieux Connaught, Canada). PENTACEL was licensed in May 1997 and first introduced into the infant vaccination schedule by some jurisdictions in July 1997, and fully incorporated into the infant schedule by all provinces and territories by April 1998. The pentavalent vaccine which contained whole cell pertussis vaccine is no longer distributed in Canada. 

To visit the new "Corrections Page" on IAC's website, go to: http://www.immunize.org/corrections/index.htm

To obtain the Web version (HTML format) of "Ask the Experts" that appeared in the fall/winter 1999-2000 issue of "NEEDLE TIPS," go to: http://www.immunize.org/nslt.d/n22/exprt22.htm

 

Immunization Action Coalition1573 Selby AvenueSt. Paul MN 55104
E-mail: admin@immunize.org Web: http://www.immunize.org/
Tel: (651) 647-9009Fax: (651) 647-9131

This page was updated on November 10, 1999